These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34230584)

  • 1. Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy.
    Wang TA; Chan WC; Tsai SH; Chen LJ
    Sci Rep; 2021 Jul; 11(1):13867. PubMed ID: 34230584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
    Baek J; Lee JH; Jung BJ; Kook L; Lee WK
    Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Pachydrusen Characteristics with Choroidal Thickness and Patient's Age in Polypoidal Choroidal Vasculopathy versus Central Serous Chorioretinopathy.
    Kim YH; Chung YR; Kim C; Lee K; Lee WK
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term effect of anti-VEGF for chronic central serous chorioretinopathy according to the presence of choroidal neovascularization using optical coherence tomography angiography.
    Song YY; Yu HY; Baek SK; Lee YH; Lee MW
    PLoS One; 2021; 16(1):e0245342. PubMed ID: 33428683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of pachyvessels in polypoidal choroidal vasculopathy.
    Ijuin N; Tsujinaka H; Hirai H; Jimura H; Nakao S; Yamashita M; Nishi T; Ueda T; Ogata N
    BMC Ophthalmol; 2020 Apr; 20(1):170. PubMed ID: 32349707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases.
    Manayath GJ; Shah VS; Saravanan VR; Narendran V
    Retina; 2018 Jun; 38(6):1195-1204. PubMed ID: 28445211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measures of vortex veins in the posterior pole in eyes with pachychoroid spectrum diseases.
    Matsumoto H; Hoshino J; Arai Y; Mukai R; Nakamura K; Kikuchi Y; Kishi S; Akiyama H
    Sci Rep; 2020 Nov; 10(1):19505. PubMed ID: 33177540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course after the onset of choroidal neovascularization in eyes with central serous chorioretinopathy.
    Kim RY; Ma GJ; Park WK; Kim M; Park YG; Park YH
    Medicine (Baltimore); 2021 Aug; 100(34):e26980. PubMed ID: 34449466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
    Park SJ; Kim BH; Park KH; Woo SJ
    Am J Ophthalmol; 2014 Dec; 158(6):1155-1163.e1. PubMed ID: 25127698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
    Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
    Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical correlates of focal choroidal excavation in eyes with age-related macular degeneration, polypoidal choroidal vasculopathy and central serous chorioretinopathy.
    Lim FP; Wong CW; Loh BK; Chan CM; Yeo I; Lee SY; Mathur R; Wong D; Wong TY; Cheung CM
    Br J Ophthalmol; 2016 Jul; 100(7):918-923. PubMed ID: 26504178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY SECONDARY TO CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Peiretti E; Iovino C; Sacconi R; Caminiti G; Querques G
    Retina; 2019 Sep; 39(9):1693-1700. PubMed ID: 29965937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy.
    Baek J; Park YH
    Am J Ophthalmol; 2015 Feb; 159(2):386-92. PubMed ID: 25447112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VERSUS PHOTODYNAMIC THERAPY IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO CENTRAL SEROUS CHORIORETINOPATHY.
    Peiretti E; Caminiti G; Serra R; Querques L; Pertile R; Querques G
    Retina; 2018 Aug; 38(8):1526-1532. PubMed ID: 28699928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
    Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
    Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy.
    Kong M; Kim SM; Ham DI
    PLoS One; 2017; 12(9):e0184058. PubMed ID: 28886052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Coherence Tomography Angiography for Diagnosis of Choroidal Neovascularization in Chronic Central Serous Chorioretinopathy after Photodynamic Therapy.
    Wu JS; Chen SN
    Sci Rep; 2019 Jun; 9(1):9040. PubMed ID: 31227727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy.
    Ooto S; Tsujikawa A; Mori S; Tamura H; Yamashiro K; Yoshimura N
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1077-86. PubMed ID: 20229103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.